Résultats de la recherche - 30 results
Linkage of individual-patient data confirm protection of prophylactic human papillomavirus vaccination against invasive cervical cancer
cancer screening data and the national cancer registry, demonstrates excellent protection against invasive cervical cancer among girls immunized at the age of 12 to 13 years with the bivalent human ...
Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis.
aim to provide updated global and regional pooled overall, type-specific, and age-specific prevalence estimates of genital HPV infection in men. METHODS: We conducted a systematic review and ...
SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe.
Volume 44, Issue 28 (2023) Keywords: Cardiovascular Diseases Diabetes Mellitus, Type 2 Europe Female Glycated Hemoglobin Heart Disease Risk Factors Humans Male middle aged Risk Factors Abstract: AIMS: To ...
Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT-2 framework.
efficiency and PCR inhibition. 1300 VALGENT-2 study samples (from women aged 20-60 attending the Scottish cervical cancer screening program) were tested with the index assay and the GP5 +/6+ PCR enzyme ...
International comparison of glycaemic control in people with type 1 diabetes: an update and extension.
(7.5-8.9%) and ≥75 mmol/mol (≥9.0%) were compared between populations for individuals aged <15, 15-24 and ≥25 years. Logistic regression was used to estimate the odds ratio (OR) of HbA < 58 mmol/mol ...
The European response to the WHO call cervical cancer as a public health problem
Issue 2 (2021) Keywords: cervical cancer screening COVID-19 elimination of cervical cancer Europe HPV vaccination WHO Abstract: The age‐standardised incidence of cervical cancer in Europe varies widely ...
Cervical cancer screening using HPV tests on self-samples: attitudes and preferences of women participating in the VALHUDES study
being investigated in the VALHUDES trial. The current study assesses attitudes and experiences regarding self-sampling among women enrolled in VALHUDES. METHODS Questionnaires from 515 women (age 25–64 ...
Tackling cervical cancer in Europe amidst the COVID-19 pandemic.
least 90% of girls by age 15 years, by offering screening at least twice in a lifetime to 70% or more of the target age populations and treat more than 90% of women with screen-detected lesions. Recently, ...
Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017)- Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia.
the guideline of the Joint National Committee of Germany (Gemeinsamer Bundesauschuss, G- BA) — that women aged 35 and above should be examined at regular intervals (at least every 3 years) and undergo ...
Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline: A 9-year Swedish nested case-control follow-up study.
Volume 125, Issue 2 (2019) Keywords: Adult Case-Control Studies Female Follow-Up Studies Human papillomavirus 16 Human papillomavirus 18 Humans middle aged Papillomaviridae Papillomavirus Infections Risk ...